Search results
Results from the WOW.Com Content Network
Leonard Abramson, founder and former chief executive officer of U.S. Healthcare [9] Angela Braly, president and chief executive officer of WellPoint from 2007 to 2012 [10] Phil Bredesen, founder and former chief executive officer of HealthAmerica Corporation, [11] as well as the founder and first chairman of Coventry Health Care [12]
The following is a list of chief executive officers of notable companies in the United States health insurance industry. In 2021, the chief executive officers of the seven largest publicly traded health insurance companies in the U.S. were paid a total of $283 million.
Pages in category "American health care chief executives" The following 200 pages are in this category, out of approximately 205 total. This list may not reflect recent changes .
Many positions at this level report to a president or chief executive officer, or to a company's board of directors. [3] People in senior executive positions of publicly traded companies are often offered stock options so it is in their interest that the company's stock price increases over time, in parallel with being accountable to investors ...
Across the business landscape, major corporations raised the levels of security afforded their executives. In the meantime, private security firms reported a marked increase in business inquiries ...
Unwarranted variations in medical practice refer to the differences in care that cannot be explained by the illness/medical need or by patient preferences. The term “unwarranted variations” was first coined by Dr. John Wennberg when he observed small area (geographic) and practice style variations, which were not based on clinical rationale. [5]
Pages in category "Chief executives in the healthcare industry" The following 4 pages are in this category, out of 4 total. This list may not reflect recent changes .
CVS Health group president and executive vice president Prem Shah told Yahoo Finance that PBMs, used by a majority of Fortune 500 companies, endeavor to lower costs of branded drugs — yet just ...